Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IRD · NASDAQ · Pharmaceutical Preparations
$3.99−0.09 (−2.21%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Opus Genetics (IRD) · oqro.io/stocks/IRD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Cormorant Asset Management, LP now owns 6.6% of IRD as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Boxer Capital Management, LLC now owns 5.4% of IRD as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 12, 2026
Adage Capital Management, L.P. cut its IRD stake below 5% (2.7%)SourceInsider trade · Traded Nov 3, 2026 · Filed Nov 5, 2026
CEO sold ~$110K of IRD shares in the open marketSourcePlanned sale · Planned for Nov 3, 2026 · Notice filed Nov 3, 2026
Officer filed to sell about $110K of IRD stockSourceInsider trade · Traded Oct 23, 2026 · Filed Oct 27, 2026
CFO sold ~$50K of IRD shares in the open marketSourceInsider trade · Traded Oct 23, 2026 · Filed Oct 27, 2026
CEO sold ~$34K of IRD shares in the open marketSourceInsider trade · Traded Oct 23, 2026 · Filed Oct 27, 2026
Director sold ~$90K of IRD shares in the open marketSourceInsider trade · Traded Oct 23, 2026 · Filed Oct 27, 2026
Director sold ~$27K of IRD shares in the open marketSourceInsider trade · Traded Dec 26, 2024 · Filed Dec 30, 2024
CEO purchased ~$98K of IRD shares in the open marketSourceInsider trade · Traded Nov 21, 2024 · Filed Nov 25, 2024
Director purchased ~$9.8K of IRD shares in the open marketSourceInsider trade · Traded Nov 15, 2024 · Filed Nov 19, 2024
CEO purchased ~$91K of IRD shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 19, 2024
CEO purchased ~$9.9K of IRD shares in the open marketSourceInsider trade · Traded Oct 23, 2026 · Filed Oct 27, 2026
Officer sold ~$17K of IRD shares in the open marketSourcePlanned sale · Planned for Oct 23, 2026 · Notice filed Oct 23, 2026
Officer filed to sell about $117K of IRD stockSourcePlanned sale · Planned for Oct 23, 2026 · Notice filed Oct 23, 2026
Officer filed to sell about $56K of IRD stockSourcePlanned sale · Planned for Oct 23, 2026 · Notice filed Oct 23, 2026
Officer filed to sell about $34K of IRD stockSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
Director sold ~$2.76M of IRD shares in the open marketSource